Unlike PRMT1, ZEB1 was not related to any of the analyzed clinicopathological parameters within different RCC types, but survival analysis revealed ZEB1 as an independent prognostic parameter of better survival of the patients with ccRCC. This evidence concerns the gene ZEB1 and nonpapillary renal cell carcinoma.